Arcutis Biotherapeutics, Inc. ARQT Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s invested capital?
- Arcutis Biotherapeutics, Inc. (ARQT) reported invested capital of $269.25M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s invested capital changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s invested capital increased by 34.8% year-over-year, from $199.74M to $269.25M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s invested capital has grown at a 4.5% compound annual growth rate (CAGR), from $208.96M to $260.78M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).